[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Prostate Cancer Devices Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030

April 2024 | 131 pages | ID: G46A48064CC0EN
APO Research

US$ 4,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Prostate cancer is cancer that starts in the prostate gland, a walnut sized gland at the base of the bladder in men. The treatment options for men with prostate cancer might include: surgery, brachytherapy, radiotherapy, hormonotherapy, chemotherapy, high intensity focused ultrasound (HIFU) and cryotherapy. In this report, the research team studied the robotic surgery, high intensity focused ultrasound (HIFU), cryotherapy, brachytherapy, and external beam radiation.

According to APO Research, The global Prostate Cancer Devices market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

North America is the largest Prostate Cancer Devices market with about 49% market share. Europe is follower, accounting for about 27% market share.

The key players are Intuitive Surgical, Varian Medical Systems, Elekta, Accuray, Bard Medical (BD), Eckert & Ziegler, Healthtronics, EDAP TMS, SonaCare Medical, Galil Medical (BTG) etc. Top 5 companies occupied about 91% market share.

This report presents an overview of global market for Prostate Cancer Devices, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Prostate Cancer Devices, also provides the value of main regions and countries. Of the upcoming market potential for Prostate Cancer Devices, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Prostate Cancer Devices revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Prostate Cancer Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global @@@@ company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.

Descriptive company profiles of the major global players, including Intuitive Surgical, Varian Medical Systems, Elekta, Accuray, Bard Medical (BD), Eckert & Ziegler, Healthtronics, EDAP TMS and SonaCare Medical, etc.

Prostate Cancer Devices segment by Company
  • Intuitive Surgical
  • Varian Medical Systems
  • Elekta
  • Accuray
  • Bard Medical (BD)
  • Eckert & Ziegler
  • Healthtronics
  • EDAP TMS
  • SonaCare Medical
  • Galil Medical (BTG)
Prostate Cancer Devices segment by Type
  • Robotic Surgery Devices
  • EBRT Devices
  • Brachytherapy
  • HIFU Devices
  • Cryotherapy Devices
Prostate Cancer Devices segment by Application
  • Hospitals
  • Ambulatory Surgical Centers
Prostate Cancer Devices segment by Region
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • China Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
Study Objectives

1. To analyze and research the global Prostate Cancer Devices status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Prostate Cancer Devices key companies, revenue, market share, and recent developments.

3. To split the Prostate Cancer Devices breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Prostate Cancer Devices market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Prostate Cancer Devices significant trends, drivers, influence factors in global and regions.

6. To analyze Prostate Cancer Devices competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostate Cancer Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prostate Cancer Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostate Cancer Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Prostate Cancer Devices industry.

Chapter 3: Detailed analysis of Prostate Cancer Devices company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Prostate Cancer Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Prostate Cancer Devices in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

Chapter 9: Concluding Insights.
1 MARKET OVERVIEW

1.1 Product Definition
1.2 Global Prostate Cancer Devices Market Size, 2019 VS 2023 VS 2030
1.3 Global Prostate Cancer Devices Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives

2 PROSTATE CANCER DEVICES MARKET DYNAMICS

2.1 Prostate Cancer Devices Industry Trends
2.2 Prostate Cancer Devices Industry Drivers
2.3 Prostate Cancer Devices Industry Opportunities and Challenges
2.4 Prostate Cancer Devices Industry Restraints

3 PROSTATE CANCER DEVICES MARKET BY COMPANY

3.1 Global Prostate Cancer Devices Company Revenue Ranking in 2023
3.2 Global Prostate Cancer Devices Revenue by Company (2019-2024)
3.3 Global Prostate Cancer Devices Company Ranking, 2022 VS 2023 VS 2024
3.4 Global Prostate Cancer Devices Company Manufacturing Base & Headquarters
3.5 Global Prostate Cancer Devices Company, Product Type & Application
3.6 Global Prostate Cancer Devices Company Commercialization Time
3.7 Market Competitive Analysis
  3.7.1 Global Prostate Cancer Devices Market CR5 and HHI
  3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
  3.7.3 2023 Prostate Cancer Devices Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion

4 PROSTATE CANCER DEVICES MARKET BY TYPE

4.1 Prostate Cancer Devices Type Introduction
  4.1.1 Robotic Surgery Devices
  4.1.2 EBRT Devices
  4.1.3 Brachytherapy
  4.1.4 HIFU Devices
  4.1.5 Cryotherapy Devices
4.2 Global Prostate Cancer Devices Sales Value by Type
  4.2.1 Global Prostate Cancer Devices Sales Value by Type (2019 VS 2023 VS 2030)
  4.2.2 Global Prostate Cancer Devices Sales Value by Type (2019-2030)
  4.2.3 Global Prostate Cancer Devices Sales Value Share by Type (2019-2030)

5 PROSTATE CANCER DEVICES MARKET BY APPLICATION

5.1 Prostate Cancer Devices Application Introduction
  5.1.1 Hospitals
  5.1.2 Ambulatory Surgical Centers
5.2 Global Prostate Cancer Devices Sales Value by Application
  5.2.1 Global Prostate Cancer Devices Sales Value by Application (2019 VS 2023 VS 2030)
  5.2.2 Global Prostate Cancer Devices Sales Value by Application (2019-2030)
  5.2.3 Global Prostate Cancer Devices Sales Value Share by Application (2019-2030)

6 PROSTATE CANCER DEVICES MARKET BY REGION

6.1 Global Prostate Cancer Devices Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global Prostate Cancer Devices Sales Value by Region (2019-2030)
  6.2.1 Global Prostate Cancer Devices Sales Value by Region: 2019-2024
  6.2.2 Global Prostate Cancer Devices Sales Value by Region (2025-2030)
6.3 North America
  6.3.1 North America Prostate Cancer Devices Sales Value (2019-2030)
  6.3.2 North America Prostate Cancer Devices Sales Value Share by Country, 2023 VS 2030
6.4 Europe
  6.4.1 Europe Prostate Cancer Devices Sales Value (2019-2030)
  6.4.2 Europe Prostate Cancer Devices Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
  6.5.1 Asia-Pacific Prostate Cancer Devices Sales Value (2019-2030)
  6.5.2 Asia-Pacific Prostate Cancer Devices Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
  6.6.1 Latin America Prostate Cancer Devices Sales Value (2019-2030)
  6.6.2 Latin America Prostate Cancer Devices Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
  6.7.1 Middle East & Africa Prostate Cancer Devices Sales Value (2019-2030)
  6.7.2 Middle East & Africa Prostate Cancer Devices Sales Value Share by Country, 2023 VS 2030

7 PROSTATE CANCER DEVICES MARKET BY COUNTRY

7.1 Global Prostate Cancer Devices Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global Prostate Cancer Devices Sales Value by Country (2019-2030)
  7.2.1 Global Prostate Cancer Devices Sales Value by Country (2019-2024)
  7.2.2 Global Prostate Cancer Devices Sales Value by Country (2025-2030)
7.3 USA
  7.3.1 Global Prostate Cancer Devices Sales Value Growth Rate (2019-2030)
  7.3.2 Global Prostate Cancer Devices Sales Value Share by Type, 2023 VS 2030
  7.3.3 Global Prostate Cancer Devices Sales Value Share by Application, 2023 VS 2030
7.4 Canada
  7.4.1 Global Prostate Cancer Devices Sales Value Growth Rate (2019-2030)
  7.4.2 Global Prostate Cancer Devices Sales Value Share by Type, 2023 VS 2030
  7.4.3 Global Prostate Cancer Devices Sales Value Share by Application, 2023 VS 2030
7.5 Germany
  7.5.1 Global Prostate Cancer Devices Sales Value Growth Rate (2019-2030)
  7.5.2 Global Prostate Cancer Devices Sales Value Share by Type, 2023 VS 2030
  7.5.3 Global Prostate Cancer Devices Sales Value Share by Application, 2023 VS 2030
7.6 France
  7.6.1 Global Prostate Cancer Devices Sales Value Growth Rate (2019-2030)
  7.6.2 Global Prostate Cancer Devices Sales Value Share by Type, 2023 VS 2030
  7.6.3 Global Prostate Cancer Devices Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
  7.7.1 Global Prostate Cancer Devices Sales Value Growth Rate (2019-2030)
  7.7.2 Global Prostate Cancer Devices Sales Value Share by Type, 2023 VS 2030
  7.7.3 Global Prostate Cancer Devices Sales Value Share by Application, 2023 VS 2030
7.8 Italy
  7.8.1 Global Prostate Cancer Devices Sales Value Growth Rate (2019-2030)
  7.8.2 Global Prostate Cancer Devices Sales Value Share by Type, 2023 VS 2030
  7.8.3 Global Prostate Cancer Devices Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
  7.9.1 Global Prostate Cancer Devices Sales Value Growth Rate (2019-2030)
  7.9.2 Global Prostate Cancer Devices Sales Value Share by Type, 2023 VS 2030
  7.9.3 Global Prostate Cancer Devices Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
  7.10.1 Global Prostate Cancer Devices Sales Value Growth Rate (2019-2030)
  7.10.2 Global Prostate Cancer Devices Sales Value Share by Type, 2023 VS 2030
  7.10.3 Global Prostate Cancer Devices Sales Value Share by Application, 2023 VS 2030
7.11 China
  7.11.1 Global Prostate Cancer Devices Sales Value Growth Rate (2019-2030)
  7.11.2 Global Prostate Cancer Devices Sales Value Share by Type, 2023 VS 2030
  7.11.3 Global Prostate Cancer Devices Sales Value Share by Application, 2023 VS 2030
7.12 Japan
  7.12.1 Global Prostate Cancer Devices Sales Value Growth Rate (2019-2030)
  7.12.2 Global Prostate Cancer Devices Sales Value Share by Type, 2023 VS 2030
  7.12.3 Global Prostate Cancer Devices Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
  7.13.1 Global Prostate Cancer Devices Sales Value Growth Rate (2019-2030)
  7.13.2 Global Prostate Cancer Devices Sales Value Share by Type, 2023 VS 2030
  7.13.3 Global Prostate Cancer Devices Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
  7.14.1 Global Prostate Cancer Devices Sales Value Growth Rate (2019-2030)
  7.14.2 Global Prostate Cancer Devices Sales Value Share by Type, 2023 VS 2030
  7.14.3 Global Prostate Cancer Devices Sales Value Share by Application, 2023 VS 2030
7.15 India
  7.15.1 Global Prostate Cancer Devices Sales Value Growth Rate (2019-2030)
  7.15.2 Global Prostate Cancer Devices Sales Value Share by Type, 2023 VS 2030
  7.15.3 Global Prostate Cancer Devices Sales Value Share by Application, 2023 VS 2030
7.16 Australia
  7.16.1 Global Prostate Cancer Devices Sales Value Growth Rate (2019-2030)
  7.16.2 Global Prostate Cancer Devices Sales Value Share by Type, 2023 VS 2030
  7.16.3 Global Prostate Cancer Devices Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
  7.17.1 Global Prostate Cancer Devices Sales Value Growth Rate (2019-2030)
  7.17.2 Global Prostate Cancer Devices Sales Value Share by Type, 2023 VS 2030
  7.17.3 Global Prostate Cancer Devices Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
  7.18.1 Global Prostate Cancer Devices Sales Value Growth Rate (2019-2030)
  7.18.2 Global Prostate Cancer Devices Sales Value Share by Type, 2023 VS 2030
  7.18.3 Global Prostate Cancer Devices Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
  7.19.1 Global Prostate Cancer Devices Sales Value Growth Rate (2019-2030)
  7.19.2 Global Prostate Cancer Devices Sales Value Share by Type, 2023 VS 2030
  7.19.3 Global Prostate Cancer Devices Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
  7.20.1 Global Prostate Cancer Devices Sales Value Growth Rate (2019-2030)
  7.20.2 Global Prostate Cancer Devices Sales Value Share by Type, 2023 VS 2030
  7.20.3 Global Prostate Cancer Devices Sales Value Share by Application, 2023 VS 2030
7.21 UAE
  7.21.1 Global Prostate Cancer Devices Sales Value Growth Rate (2019-2030)
  7.21.2 Global Prostate Cancer Devices Sales Value Share by Type, 2023 VS 2030
  7.21.3 Global Prostate Cancer Devices Sales Value Share by Application, 2023 VS 2030

8 COMPANY PROFILES

8.1 Intuitive Surgical
  8.1.1 Intuitive Surgical Comapny Information
  8.1.2 Intuitive Surgical Business Overview
  8.1.3 Intuitive Surgical Prostate Cancer Devices Revenue and Gross Margin (2019-2024)
  8.1.4 Intuitive Surgical Prostate Cancer Devices Product Portfolio
  8.1.5 Intuitive Surgical Recent Developments
8.2 Varian Medical Systems
  8.2.1 Varian Medical Systems Comapny Information
  8.2.2 Varian Medical Systems Business Overview
  8.2.3 Varian Medical Systems Prostate Cancer Devices Revenue and Gross Margin (2019-2024)
  8.2.4 Varian Medical Systems Prostate Cancer Devices Product Portfolio
  8.2.5 Varian Medical Systems Recent Developments
8.3 Elekta
  8.3.1 Elekta Comapny Information
  8.3.2 Elekta Business Overview
  8.3.3 Elekta Prostate Cancer Devices Revenue and Gross Margin (2019-2024)
  8.3.4 Elekta Prostate Cancer Devices Product Portfolio
  8.3.5 Elekta Recent Developments
8.4 Accuray
  8.4.1 Accuray Comapny Information
  8.4.2 Accuray Business Overview
  8.4.3 Accuray Prostate Cancer Devices Revenue and Gross Margin (2019-2024)
  8.4.4 Accuray Prostate Cancer Devices Product Portfolio
  8.4.5 Accuray Recent Developments
8.5 Bard Medical (BD)
  8.5.1 Bard Medical (BD) Comapny Information
  8.5.2 Bard Medical (BD) Business Overview
  8.5.3 Bard Medical (BD) Prostate Cancer Devices Revenue and Gross Margin (2019-2024)
  8.5.4 Bard Medical (BD) Prostate Cancer Devices Product Portfolio
  8.5.5 Bard Medical (BD) Recent Developments
8.6 Eckert & Ziegler
  8.6.1 Eckert & Ziegler Comapny Information
  8.6.2 Eckert & Ziegler Business Overview
  8.6.3 Eckert & Ziegler Prostate Cancer Devices Revenue and Gross Margin (2019-2024)
  8.6.4 Eckert & Ziegler Prostate Cancer Devices Product Portfolio
  8.6.5 Eckert & Ziegler Recent Developments
8.7 Healthtronics
  8.7.1 Healthtronics Comapny Information
  8.7.2 Healthtronics Business Overview
  8.7.3 Healthtronics Prostate Cancer Devices Revenue and Gross Margin (2019-2024)
  8.7.4 Healthtronics Prostate Cancer Devices Product Portfolio
  8.7.5 Healthtronics Recent Developments
8.8 EDAP TMS
  8.8.1 EDAP TMS Comapny Information
  8.8.2 EDAP TMS Business Overview
  8.8.3 EDAP TMS Prostate Cancer Devices Revenue and Gross Margin (2019-2024)
  8.8.4 EDAP TMS Prostate Cancer Devices Product Portfolio
  8.8.5 EDAP TMS Recent Developments
8.9 SonaCare Medical
  8.9.1 SonaCare Medical Comapny Information
  8.9.2 SonaCare Medical Business Overview
  8.9.3 SonaCare Medical Prostate Cancer Devices Revenue and Gross Margin (2019-2024)
  8.9.4 SonaCare Medical Prostate Cancer Devices Product Portfolio
  8.9.5 SonaCare Medical Recent Developments
8.10 Galil Medical (BTG)
  8.10.1 Galil Medical (BTG) Comapny Information
  8.10.2 Galil Medical (BTG) Business Overview
  8.10.3 Galil Medical (BTG) Prostate Cancer Devices Revenue and Gross Margin (2019-2024)
  8.10.4 Galil Medical (BTG) Prostate Cancer Devices Product Portfolio
  8.10.5 Galil Medical (BTG) Recent Developments

9 CONCLUDING INSIGHTS

10 APPENDIX

10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
  10.5.1 Secondary Sources
  10.5.2 Primary Sources
10.6 Disclaimer


More Publications